|
Re: RRR %
|
4
|
Resverlogix Corp.
|
Jul 01, 2019 12:54PM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
4
|
Resverlogix Corp.
|
Sep 30, 2019 10:11AM
|
|
Re: BTI:TSXV; BIOAF:OTCQB: "Announces Rare Diseases Strategic Alliance With Chiesi"
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jun 29, 2020 04:31PM
|
|
Re: RVX buyout projection at $30 US minimum
|
4
|
Resverlogix Corp.
|
Nov 01, 2018 05:33PM
|
|
Re: April showers bring May flowers...
|
4
|
Resverlogix Corp.
|
May 01, 2017 08:17AM
|
|
Re: BETonMACE Placebo Estimate
|
4
|
Resverlogix Corp.
|
Feb 23, 2019 11:46AM
|
|
Re: I think one major reason that,
|
4
|
Resverlogix Corp.
|
Nov 01, 2019 05:39PM
|
|
Re: Gran Oso....
|
4
|
Resverlogix Corp.
|
Nov 19, 2019 08:55AM
|
|
Re: New version of May slide deck and ERA-EDTA Conference & Symposium
|
4
|
Resverlogix Corp.
|
May 23, 2018 01:41PM
|
|
Re: News! - COVID 19 pre-clinical and clinical research trials
|
4
|
Resverlogix Corp.
|
Jun 01, 2020 09:39AM
|
|
Re: Zenith AGM webcast 9/12/2018
|
4
|
Zenith Epigenetics
|
Sep 11, 2018 03:38PM
|
|
Re: AGM 2018 - Masila Notes
|
4
|
Resverlogix Corp.
|
Sep 13, 2018 08:21AM
|
|
Re: AHA late breakers....
|
4
|
Resverlogix Corp.
|
Sep 19, 2019 04:46PM
|
|
Re: Arvinas /ARVN dBET vs iBET
|
4
|
Zenith Epigenetics
|
Oct 13, 2018 03:41PM
|
|
Re: Resverlogix H2 2018 events
|
4
|
Resverlogix Corp.
|
Oct 16, 2018 11:51AM
|
|
Re: Why such little intrest, so close to the finis
|
4
|
Resverlogix Corp.
|
Nov 16, 2018 04:38PM
|
|
Re: New insights from this study -- Questions for scientists.
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 12:18PM
|
|
Re: The short report is out....can someone check and post the number?
|
4
|
Resverlogix Corp.
|
Jun 06, 2019 01:46PM
|
|
Re: New article on BET Inhibitors in Cardiovascular Disease
|
4
|
Resverlogix Corp.
|
Jan 30, 2019 03:09PM
|
|
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism
|
4
|
Resverlogix Corp.
|
May 24, 2016 02:58PM
|
